Medical Weight Loss for Newark, Ohio Residents
Newark, Ohio residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Newark through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Newark Residents Choose New Hope Weight Loss
Newark patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Ohio and beyond since 2020.
If you are searching for medical weight loss in Newark, New Hope Weight Loss treats patients statewide by telehealth from our Costa Mesa, California clinic. Dr. Sharma reviews your history by secure video and, if appropriate, prescribes compounded semaglutide or tirzepatide shipped to you.
Although our clinic is physically in Costa Mesa, California, Newark residents receive the same physician-supervised care without leaving Ohio. We care for patients throughout downtown Newark and the greater Licking County area east of Columbus. Whether you are starting your first GLP-1 program or switching from a brand medication, your Newark treatment plan is built around your health history and goals.
For Newark residents, being seen by video means starting this week instead of waiting for an in-person appointment. Pricing for Newark is the same as everywhere: $119 for the review, $166/month for semaglutide, and $233/month for tirzepatide, with medication billed separately.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Newark
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Newark
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Newark address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Newark
How do I get treatment from Newark?
As a Newark, Ohio patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Newark?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Newark in cold-pack packaging, no lines and no drive.
How much does it cost for Newark patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Newark do you serve?
We serve patients from across Newark by telehealth, including downtown Newark and the greater Licking County area east of Columbus.
What support is there for side effects for Newark patients?
Dr. Sharma starts Newark patients at a low dose and titrates slowly to limit nausea and GI effects, and your health advisor is reachable between visits by phone, WhatsApp, or message to adjust the plan if needed.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Newark, Ohio by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.